Keyword Analysis & Research: risankizumab vs ustekinumab
Keyword Analysis
Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
risankizumab vs ustekinumab | 0.11 | 0.2 | 2292 | 88 | 27 |
risankizumab | 0.87 | 0.4 | 2354 | 91 | 12 |
vs | 1.85 | 1 | 4212 | 4 | 2 |
ustekinumab | 0.6 | 0.7 | 4489 | 37 | 11 |
Keyword Research: People who searched risankizumab vs ustekinumab also searched
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
risankizumab vs ustekinumab | 0.04 | 0.3 | 2532 | 86 |
risankizumab vs ustekinumab for psoriasis | 1.05 | 0.4 | 9685 | 50 |
risankizumab vs ustekinumab crohn's disease | 0.47 | 0.1 | 2535 | 75 |
risankizumab vs ustekinumab crohn's | 1.87 | 0.9 | 3448 | 34 |
ustekinumab for psoriatic arthritis | 0.24 | 0.1 | 1169 | 8 |
risankizumab phase 2 psoriasis | 1.67 | 0.5 | 2120 | 6 |
secukinumab to treat psoriasis medications | 1.95 | 0.7 | 4818 | 88 |
risankizumab on body device | 0.9 | 1 | 1938 | 51 |
secukinumab psoriatic arthritis treatment | 0.72 | 1 | 8630 | 49 |
bimekizumab psoriasis fda approval | 0.78 | 0.1 | 6766 | 32 |
curative adalimumab for psoriasis | 1.02 | 0.8 | 4106 | 79 |
nice secukinumab psoriatic arthritis | 1.06 | 0.5 | 512 | 34 |
bimekizumab psoriasis phase 3 | 0.7 | 0.5 | 4631 | 53 |
risankizumab fda approval history | 1.47 | 0.2 | 7506 | 21 |
risankizumab-rzaa | 0.67 | 0.4 | 7630 | 100 |